[Anticancer drugs and ABC transporters]

Area of Science:

• Pharmacology
• Molecular Biology
• Oncology

Background:

• Anticancer drugs require specific pharmacokinetics for efficacy.
• ATP-binding cassette (ABC) transporters play a key role in drug absorption and excretion.
• ABC transporters mediate drug resistance by exporting drugs from cells or sequestering them.

Purpose of the Study:

• To review the role of ABC transporters in cancer chemotherapy.
• To highlight the clinical significance of ABC transporters in drug resistance and pharmacokinetics.
• To discuss the impact of ABC transporter genetic variations on treatment outcomes.

Main Methods:

• Literature review of ABC transporter functions in cancer chemotherapy.
• Analysis of ABC transporter involvement in drug absorption, distribution, metabolism, and excretion.
• Examination of specific ABC transporters (e.g., P-glycoprotein, BCRP) and their substrate drugs.
• Discussion of ABC gene polymorphism and its clinical implications.

Main Results:

• ABC transporters significantly influence intracellular drug concentrations and contribute to multidrug resistance.
• Key ABC transporters like P-glycoprotein/ABCB1 and BCRP/ABCG2 are implicated in resistance to various anticancer agents, including molecular-targeted drugs.
• Polymorphisms in ABC genes affect drug pharmacokinetics, treatment efficacy, and adverse drug reactions.
• ABC transporters are involved in both drug excretion and absorption processes.

Conclusions:

• ABC transporters are critical determinants of anticancer drug efficacy and resistance.
• Targeting or accounting for ABC transporter activity is essential for optimizing cancer chemotherapy.
• Further research into ABC transporter function and genetic variability is needed for clinical application.